{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:27:32Z","timestamp":1778876852672,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Hepatocellular carcinoma (HCC) metastases to the zygomatic bone are extremely uncommon, and the treatment of target drugs against such case is unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 48-year-old male patient was admitted to our hospital under suspicion of an advanced liver tumor due to an increase in levels of alpha-fetoprotein (AFP) after radiofrequency ablation for independent nodule in his liver 1 month before. He had a hepatitis B virus (HBV) history for 20 years without treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis and interventions:<\/jats:title>\n            <jats:p>A diagnosis of primary HCC was made based on pathological examination following right hepatectomy. Seven months after the surgery, a mass in S8 was identified and treated by ARF. Twenty days later, a right zygomatic mass was observed and the incisional biopsy revealed metastasis from HCC. Due to side effects of chemotherapy, the metastatic zygomatic mass was treated with radioactive seed implantation. Despite these interventions, there was steady increase in AFP values as well as increase in size of the zygomatic mass. Hence, the patient was started on apatinib with a dose of 500\u200amg\/day from 1 to 28 days per cycle for a duration of 10 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The AFP values were significantly decreased but the size of the zygomatic mass continued to increase indicating progression of disease. But the progression-free survival was more than 10 months. The patient exhibited adverse reactions which were controllable by symptomatic treatments. As of last follow-up, the patient is unwell with pain in the face, blurred vision in the right eye, dyscrasia, and exhibited difficulty in opening his mouth.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>HCC metastases to the zygomatic bone are very aggressive with a very low incidence and immunohistochemistry is useful diagnostic indicators. Still now, there is no optimal treatment strategy for these patients. Apatinib may be a promising drug in the treatment of HCC metastases to the zygomatic bone.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014595","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:02:08Z","timestamp":1556794928000},"page":"e14595","source":"Crossref","is-referenced-by-count":8,"title":["Zygomatic bone metastasis from hepatocellular carcinoma and the therapeutic efficacy of apatinib"],"prefix":"10.1097","volume":"98","author":[{"given":"Qiucheng","family":"Lei","sequence":"first","affiliation":[{"name":"Department of Hepatopancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huazhen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First People's Hospital of Foshan, the Affiliated Foshan Hospital of Sun Yat-Sen University, Guangdong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiwen","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongdang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuojun","family":"Zhen","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MCG.0b013e3181d46ef2","article-title":"Hepatocellular carcinoma (HCC): a global perspective","volume":"44","author":"Ferenci","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R2-20230914","first-page":"1","article-title":"Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis","volume":"43","author":"Tang","year":"2017","journal-title":"Abdom Radiol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00000421-199808000-00014","article-title":"Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients","volume":"21","author":"Pawarode","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"R6-20230914","first-page":"675","article-title":"Zygomatic bone metastasis as an initial presentation of hepatocellular carcinoma","volume":"16","author":"Tomanovic","year":"2013","journal-title":"Arch Iran Med"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrclinonc.2016.53","article-title":"Targeted therapy: Apatinib - new third-line option for refractory gastric or GEJ cancer","volume":"13","author":"Aoyama","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"105596","DOI":"10.18632\/oncotarget.22337","article-title":"Apatinib is effective for treatment of advanced hepatocellular carcinoma","volume":"8","author":"Kong","year":"2017","journal-title":"Oncotarget"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"e9704","DOI":"10.1097\/MD.0000000000009704","article-title":"Efficacy and Safety of apatinib in patients with intermediate\/advanced hepatocellular carcinoma: a prospective observation study","volume":"97","author":"Yu","year":"2018","journal-title":"Medicine"},{"issue":"(15 suppl)","key":"R11-20230914","article-title":"Apatinib in Chinese patients with advanced hepatocellular carcinoma: a phase II randomized, open-label trial","volume":"32","author":"Qin","year":"2014","journal-title":"Asco Meeting Abstracts"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000343828","article-title":"Treatment of hepatocellular carcinoma: a systematic review","volume":"1","author":"Lin","year":"2012","journal-title":"Liver Cancer"},{"key":"R13-20230914","first-page":"2824","article-title":"The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review","volume":"120","author":"Fong","year":"2014","journal-title":"Cancer-Am Cancer Soc"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1590-8658(10)60507-5","article-title":"The changing pattern of epidemiology in hepatocellular carcinoma","volume":"42","author":"Nordenstedt","year":"2010","journal-title":"Dig Liver Dis"},{"key":"R15-20230914","first-page":"1991","article-title":"Bone metastasis in hepatocellular carcinoma","volume":"55","author":"Okazaki","year":"1985","journal-title":"Cancer-Am Cancer Soc"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0973-1482.42257","article-title":"Bone metastasis in hepatocellular carcinoma: need for reappraisal of treatment","volume":"4","author":"Attili","year":"2008","journal-title":"J Cancer Res Ther"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1079-2104(98)90373-0","article-title":"Initial presentation of hepatocellular carcinoma as a mandibular mass: case report and review of the literature","volume":"86","author":"Chin","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.1970.03170380052016","article-title":"Unusual osseous metastases of hepatoma","volume":"213","author":"Reichbach","year":"1970","journal-title":"JAMA"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/014556130208100118","article-title":"Hepatocellular cancer metastatic to the zygoma: primary resection and immediate reconstruction","volume":"81","author":"Neff","year":"2002","journal-title":"Ear Nose Throat J"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2009.12.028","article-title":"Electronic images of the month. An unusual presentation of hematemesis: a presentation of maxillary metastasis from hepatocellular carcinoma","volume":"8","author":"Bair","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2298\/VSP1104359K","article-title":"Metastasis of hepatocellular carcinoma presented as a tumor of the maxillary sinus and retrobulbar tumor","volume":"68","author":"Kolarevic","year":"2011","journal-title":"Vojnosanit Pregl"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12029-017-9998-6","article-title":"Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management-single-center experience","volume":"48","author":"Bhatia","year":"2017","journal-title":"J Gastrointest Cancer"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.amjoto.2006.08.012","article-title":"Sinonasal metastatic hepatocellular carcinoma","volume":"28","author":"Huang","year":"2007","journal-title":"Am J Otolaryngol"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1478-3231.2005.01094.x","article-title":"Radiotherapy for painful bone metastases from hepatocellular carcinoma","volume":"25","author":"Seong","year":"2005","journal-title":"Liver Int"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5009\/gnl14009","article-title":"Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma","volume":"9","author":"Choi","year":"2015","journal-title":"Gut Liver"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"e3598","DOI":"10.1097\/MD.0000000000003598","article-title":"The use of apatinib in treating nonsmall-cell lung cancer: case report and review of literature","volume":"95","author":"Ding","year":"2016","journal-title":"Medicine"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1349-7006.2011.01939.x","article-title":"YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo","volume":"102","author":"Tian","year":"2011","journal-title":"Cancer Sci"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"20510","DOI":"10.18632\/oncotarget.14724","article-title":"Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review","volume":"8","author":"Kou","year":"2017","journal-title":"Oncotarget"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/15384047.2017.1323589","article-title":"Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: a single-center randomized controlled trial","volume":"18","author":"Wei","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"e9598","DOI":"10.1097\/MD.0000000000009598","article-title":"The radiosensitive effect of apatinib for hepatocellular carcinoma patient with big paraspinal metastasis: a case report","volume":"97","author":"Zhu","year":"2018","journal-title":"Medicine"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"e11214","DOI":"10.1097\/MD.0000000000011214","article-title":"The excellent antitumor effect of apatinib alone as second-line therapy in a patient with sorafenib-refractory hepatocellular carcinoma: a case report","volume":"97","author":"Zhu","year":"2018","journal-title":"Medicine"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201905030-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:28:30Z","timestamp":1694726910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201905030-00001"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":30,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014595","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}